Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The revision tag has been updated to v3.5.3, replacing the previous v3.5.0 in the revision history. This represents a metadata update with no substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-28T10:46:09.000Z thumbnail image
  2. Check
    22 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    The Veneto, Italy site listing changed from Padua to Padova (postal code 35128).
    Difference
    0.0%
    Check dated 2026-04-06T03:10:48.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new publication citation has been added to the Publications section: 'Assessing side-effect bother, burden, and tolerability: A qualitative study exploring the content validity of the Functional Assessment of Cancer Therapy - Item GP5.' This reference provides additional context for the study's reported outcomes but does not modify study design or participant information.
    Difference
    0.0%
    Check dated 2026-03-30T01:57:07.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Napoli, Campania, Italy, 80131 was renamed to Naples, Campania, Italy, 80131 and a Naples listing was added, with the page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T21:21:45.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T04:41:08.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This appears to be a version control update with no visible changes to study information or page layout.
    Difference
    0.0%
    Check dated 2026-02-14T13:14:56.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.